Elixir Medical Corporation
Elixir Medical Corporation Announced Positive First-In-Man Results from Three Drug Eluting Coronary Stent Systems
Published in Cardiovascular Business Week, November 4th, 2008
"Elixir is committed to be a leader in drug eluting stents by addressing physician and patient needs through the efficient development of a broad and innovative portfolio of products," said Motasim Sirhan, chief executive officer of Elixir Medical Corporation. "We are excited about the promise of both Novolimus and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- American Heart Association
Heart360 Gives 'All Around' Perspective to Heart Health - American Heart Association
JAMA Study Highlights Question - Are Hospitals Treating Older, Sicker and Minority Populations Being Evaluated Fairly for Pay for Performance? - AntiCancer, Inc.
A/C Diagnostics Unit of AntiCancer, Inc., Receives FDA Clearance for a Portable Homocysteine Test - ARAMARK
Taking the Fright out of Halloween Treats: ARAMARK Dietitians Offer a Tasty Twist to Seasonal Sweets - Arrhythmia
Abbott Laboratories reports research in arrhythmia - Biopharmaceuticals
ARCA biopharma to Present at Seventh Annual BIO Investor Forum - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
